Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Simen H. Hansen"'
Autor:
Kristin J. Skaarud, Johannes R. Hov, Simen H. Hansen, Martin Kummen, Jørgen Valeur, Ingebjørg Seljeflot, Asta Bye, Vemund Paulsen, Knut E. A. Lundin, Marius Trøseid, Geir E. Tjønnfjord, Per Ole Iversen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Gut mucosal barrier injury is common following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and associated with poor clinical outcomes. Diet is critical for microbial diversity, but whether nutritional support affects micro
Externí odkaz:
https://doaj.org/article/506291e3837948b684d37c1e58ee93fd
Autor:
Laura Valestrand, Fei Zheng, Simen H. Hansen, Jonas Øgaard, Johannes R. Hov, Niklas K. Björkström, Tom H. Karlsen, Xiaojun Jiang, Espen Melum
Primary sclerosing cholangitis (PSC) is associated with altered microbiota of the gut and bile. Mucosal-associated invariant T (MAIT) cells, enriched in human liver, uniquely recognize microbial-derived metabolites. This study aimed to determine whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::540a6d0317497ebd1160562399009532
http://hdl.handle.net/10852/97620
http://hdl.handle.net/10852/97620
Autor:
Martin Kummen, Louise B. Thingholm, Malte-Christoph Rühlemann, Kristian Holm, Simen H. Hansen, Lucas Moitinho-Silva, Timur Liwinski, Roman Zenouzi, Christopher Storm-Larsen, Marte L. Høyvik, Marius Trøseid, Mette Vesterhus, Matthias Laudes, Wolfgang Lieb, Tom Hemming Karlsen, Corinna Bang, Christoph Schramm, Andre Franke, Johannes R. Hov
Publikováno v:
Journal of Hepatology. 73:S197-S198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e651bb434b1a2a009ea29d7b463856a
https://doi.org/10.1016/s0168-8278(20)30901-6
https://doi.org/10.1016/s0168-8278(20)30901-6
Autor:
Mikal Jacob Hole, Kristin Kaasen Jørgensen, Simen H. Hansen, Alexandra Götz, Kirsten Muri Boberg, Tom Hemming Karlsen, Martin Kummen, Johannes R. Hov
Publikováno v:
Journal of Hepatology. 73:S200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17115f975394ce8f56165235d729894b
https://doi.org/10.1016/s0168-8278(20)30906-5
https://doi.org/10.1016/s0168-8278(20)30906-5
Autor:
Ayodeji Awoyemi, Cristiane Mayerhofer, Alex S Felix, Johannes R Hov, Samuel D Moscavitch, Knut Tore Lappegård, Anders Hovland, Sigrun Halvorsen, Bente Halvorsen, Ida Gregersen, Asbjørn Svardal, Rolf K Berge, Simen H Hansen, Alexandra Götz, Kristian Holm, Pål Aukrust, Sissel Åkra, Ingebjørg Seljeflot, Svein Solheim, Andrea Lorenzo, Lars Gullestad, Marius Trøseid, Kaspar Broch
Publikováno v:
EBioMedicine, Vol 70, Iss , Pp 103511- (2021)
Background: The gut microbiota represents a potential treatment target in heart failure (HF) through microbial metabolites such as trimethylamine N-oxide (TMAO) and systemic inflammation. Treatment with the probiotic yeast Saccharomyces boulardii hav
Externí odkaz:
https://doaj.org/article/7a3b3ad0db934ab9973249e4de4fc5e4